J M VonTeichert

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Bisphosphonates are potent inhibitors of bone resorption and provide a therapeutic benefit for patients with bone metastases. Zoledronic acid is a highly potent, nitrogen-containing bisphosphonate. In the present trial, we assessed the safety and tolerability of increasing doses of zoledronic acid and its effects on urinary markers of bone resorption in(More)
  • 1